Buzz Stocks: CVS Health Corp, Valeant Pharmaceuticals Intl Inc, and Facebook Inc

Today's stocks to watch in the news include CVS Health Corp (CVS), Valeant Pharmaceuticals Intl Inc (VRX), and Facebook Inc (FB)

Nov 8, 2016 at 9:22 AM
facebook X logo linkedin


After Monday's monster session, U.S. stocks look like they'll take a breather, as voting in the U.S. presidential election gets underway. Among specific equities in focus today are pharmacy chain CVS Health Corp (NYSE:CVS), drugmaker Valeant Pharmaceuticals Intl Inc (NYSE:VRX), and social media stock Facebook Inc (NASDAQ:FB). Here's a quick look at what's driving CVS, VRX, and FB.

  • CVS is poised to plunge 15.1% at the open -- and flirt with levels not touched since early 2014 -- after the company cut its full-year profit forecast, citing "slowing prescription growth in overall market, as well as a soft seasonal business." This, despite quarterly earnings topping expectations. Assuming CVS Health Corp shares crater, analysts may start to rethink their collectively optimistic approach. Among the 19 analysts tracking the stock, 15 have dished out a "buy" or better opinion, versus four "holds" and not one "sell." In other words, CVS could be vulnerable to downgrades. As of last night's close, the stock was sitting at $83.39, already 14.7% lower in 2016.
  • VRX shareholders are bracing for a rough day, with the stock pointed 27.9% lower pre-market after an earnings miss and a full-year guidance cut. If these losses materialize, it would translate into a fresh six-year low for the stock. Meanwhile, Valeant Pharmaceuticals Intl Inc options traders may be on pins and needles. Over the past 10 weeks, the shares have racked up a 50-day International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) call/put volume ratio of 2.17 -- in the bullishly skewed 97th annual percentile. Yesterday, VRX closed at $19.13, yielding a year-to-date deficit beyond 81%.
  • FB is testing a feature that gives page administrators the ability to post jobs and receive applications, potentially turning up the heat on networking peer LinkedIn, as well as more traditional job sites. Technically speaking, Facebook Inc shares have been strong in 2016, advancing nearly 17% to trade at $122.15. Understandably, short sellers have been shy to bet against the social media powerhouse. In fact, less than 1% of FB's float is sold short, after short interest dropped 5.5% in the most recent reporting period.

Stay on top of overnight news & big morning movers. Sign up now for Schaeffer's Opening View.

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI